28 March 2017
News and Views
Links and Services
This week's issue of the Journal of the Amercian Medical Association examines the effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib.
Aside from the multikinase inhibitor sorafenib, there are no effective systemic therapies for the
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors